4
Changes in Ownership
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Filed Acc 0001127602-22-016211
Corporate Executive VP & CFO acquired 1,637 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Pease Flavia Corporate Executive VP & CFO | 2022-05-27 | Grant or award | +1,637 | 6,822 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Pease Flavia Corporate Executive VP & CFO | 2022-05-27 | Grant or award · Stock Options (Right to Buy) | +4,423 | $244.41 | $1,081,025 | 4,423 | D: show line 2 in the form |
Loading xslF345X03/form4.xml…